Testicular Cancer

Testicular germ cell tumors are the most curable solid malignancy, with cisplatin-based chemotherapy achieving >95% cure in localized disease and durable cures even in metastatic disease. Treatment is risk-stratified by the IGCCCG classification; the BEP regimen (bleomycin, etoposide, cisplatin) is the frontline backbone, with etoposide/cisplatin (EP) and salvage regimens (TIP, VeIP) and high-dose chemotherapy for relapse.

Approved drugs, investigational agents, and relevant clinical trials for this disease area.

Approved Drugs for Testicular Cancer

• Cisplatin (Platinol) — Alkylating Agent
• Etoposide (VePesid) — Topoisomerase Inhibitor
• Bleomycin (Blenoxane) — Other
• Ifosfamide (Ifex) — Alkylating Agent
• Carboplatin (Paraplatin) — Alkylating Agent
• Paclitaxel (Taxol) — Taxane
• Gemcitabine (Gemzar) — Antimetabolite
• Vinblastine (Velban) — Vinca Alkaloid
• Oxaliplatin (Eloxatin) — Alkylating Agent